FLAGYL

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Malta, Mexico, Netherlands, New Zealand, Nigeria, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug FLAGYL contains one active pharmaceutical ingredient (API):

1	Methronidazole UNII 140QMO216E - METRONIDAZOLE
	Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.
	Read more about Methronidazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLAGYL Suppositories, Oral suspension	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G01AF01	Metronidazole	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF01
J01XD01	Metronidazole	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives
Discover more medicines within J01XD01
P01AB01	Metronidazole	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01A Agents against amoebiasis and other protozoal diseases → P01AB Nitroimidazole derivatives
Discover more medicines within P01AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1621H, 1630T, 1636D, 1642K, 3339R, 3341W, 5155H, 5157K
BR	Câmara de Regulação do Mercado de Medicamentos	502804501112319, 502804504111313, 502804505150312, 502814070066903, 576720050067217, 576720050067317, 576720050067417, 576720050067517
CA	Health Products and Food Branch	01926853, 01926861
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.397-1-01-12, 24.405-1-12-11, 24.482-1-02-12, 24.483-1-02-12
EE	Ravimiamet	1162594
ES	Centro de información online de medicamentos de la AEMPS	34985, 35034, 47656, 55233, 59325
FI	Lääkealan turvallisuus- ja kehittämiskeskus	000019, 151217, 398800
FR	Base de données publique des médicaments	61659061, 62708127, 65020253, 67965563, 68818192
GB	Medicines & Healthcare Products Regulatory Agency	15509, 15702, 39106, 39120
HK	Department of Health Drug Office	31148, 31150
IE	Health Products Regulatory Authority	25267, 25577, 25666, 41947
IL	מִשְׂרַד הַבְּרִיאוּת	806, 807
IT	Agenzia del Farmaco	018505038
JP	医薬品医療機器総合機構	2529707H1063, 6419002F1131
MT	Medicines Authority	AA565/03902, MA1359/02001, MA1359/02003, PI1438/05901A, PI1438/05902A, PI521/05401B, PI521/05402B, PI908/02501A, PI908/02502A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	0417M79, 55754, 62207, 78445
NG	Registered Drug Product Database	A4-3947
NL	Z-Index G-Standaard	13549138
NL	Z-Index G-Standaard, PRK	22918, 5207
NZ	Medicines and Medical Devices Safety Authority	1473, 1476
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63535001, W63536001
SG	Health Sciences Authority	00142P, 01557P, 02201P
TN	Direction de la Pharmacie et du Médicament	9103501, 9263331
TR	İlaç ve Tıbbi Cihaz Kurumu	8699586690051, 8699586690068, 8699809098572, 8699809706644
US	FDA, National Drug Code	0025-1821, 0025-1942
ZA	Health Products Regulatory Authority	D/20.2.6/228, F/20.2.6/50, J/20.2/151, K/20.2/15, K/20.2/16, Z/20.2.6/295, Z/20.2.6/296